Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biol...
The FDA approved a CRISPR-based medicine to treat beta thalassemia, an inherited...
More than half of those responsible for registering clinical trials and reportin...
The federal government is overpaying Medicare Advantage plans more than ever, co...
As Congress hurtles toward another government funding deadline, lawmakers are st...
Novo Nordisk resumed shipments of the 1.7-milligram dose of its Wegovy weight lo...
Want to stay on top of the science and politics driving biotech today? Sign up t...
NIH director Monica Bertagnolli is at the center of the drug pricing debate over...
Cord blood banking sounds like a great idea — until you realize what it costs ba...
Can flu shots be reformulated in time for the 2024-25 flu season? Manufacturers ...
Only 17% of physicians surveyed felt they understood the FDA’s medical devices a...
Some doctors see private equity as the only way for their practices to survive —...
BMI as a barrier to orthopedic surgery doesn't make sense for patient health.
Want to stay on top of the science and politics driving biotech today? Sign up t...
Drug Farm’s ALPK1 inhibitor DF-003 is being investigated in a Phase I trial for ...
If new treatments are shown to maintain weight loss, they will become game chang...
